Integra LifeSciences logo
Integra LifeSciences
IART | NASDAQ
Chart Builder DCF Calculator
$13.98
-$0.42 (-2.92%)
At close: Nov 16, 2026, 4:00 PM ET
$13.98
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

Integra LifeSciences Company Profile

Company profile explained

Company Profile

Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.

Key Executives

Name Position
Stuart Essig CEO, President & Chairman
Lea Daniels Knight Executive Vice President & Chief Financial Officer
Michael D. Hutchinson Executive Vice President, Chief Legal Officer & Secretary
Teshtar Elavia Corporate VP & Chief Technology Officer
Christopher Ward Senior Director of Investor Relations
Harvinder Singh Executive Vice President & President of International Business
Jeffrey Mosebrook Senior Vice President of Finance & Principal Accounting Officer
Laurene Isip Vice President of Global Corporate Communications & Public Relations
Michael J. McBreen Executive VP & Chief Commercial Officer
Robert T. Davis Jr. Executive Vice President of Tissue Reconstruction and Distributed Technologies

Latest SEC Filings

Date Type Title
Oct 23, 2026 10-Q Quarterly Report
Oct 21, 2026 8-K Current Report
Oct 19, 2026 8-K Current Report
Oct 13, 2026 3 Filing
Oct 09, 2026 8-K Current Report
Oct 02, 2026 8-K Current Report
Sep 28, 2026 3 Filing
Sep 08, 2026 8-K Current Report
Sep 04, 2026 4 Filing
Aug 13, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
View All SEC Filings ➞
Integra LifeSciences
Integra LifeSciences logo
Country United States
IPO Date Aug 16, 1995
Industry Medical - Devices
Sector Healthcare
Employees 4,427
CEO Stuart Essig

Contact Details

1100 Campus Road Princeton, New Jersey 08540 United States

Stock Details

Ticker Symbol IART
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000917520
CUSIP Number 457985208
ISIN Number US4579852082
SIC Code 3841

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.